Felix Gerhard Maria Dietlein, M.D., Ph.D.
This page shows the publications Felix Dietlein has written about Enzyme Inhibitors.
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer. Cell. 2015 Jul 02; 162(1):146-59.
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc Natl Acad Sci U S A. 2012 Oct 16; 109(42):17034-9.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.